Home » Topics » Regulatory » Patents

Patents
RSS

Neurogen describes dopamine receptor subtype-specific ligands

Nov. 11, 1997

New oxazolidinone antibiotics described by Zeneca

Nov. 11, 1997

New taxoids from RPR

Nov. 10, 1997

Inhibitors of ECE prepared at Roussel Uclaf/INSERM

Nov. 10, 1997

Novartis reports protein tyrosine kinase inhibitors for bone disorders

Nov. 10, 1997

Quinoxalinediones for neurodegenerative/neurological disorders patented

Nov. 10, 1997

Fibrinogen antagonists from Merck & Co.

Nov. 10, 1997

Takeda describes new melatonin agonists

Nov. 10, 1997

Peripherally acting opioid analgesics described by Astra

Nov. 7, 1997

Roussel Uclaf reports new erythromycin antibiotics

Nov. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...